References
-
1
Bremner J D.
A double-blind comparison of Org 3770, amitriptyline and placebo in major depression.
J Clin Psychiatry.
1995;
56
(11)
519-526
-
2 Fachinformation Remergil .cited in: Remergil - Wissenschaftliche Information. München; Organon GmbH 2000
-
3
Grohmann R, Ruther E, Engel R R, Hippius H.
Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRL.
Pharmacopsychiatry.
1999;
32
21-28
-
4
Kasper S.
Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data.
Int Clin Psychopharmacol.
1995;
10
(Suppl. 4)
25-35
-
5
Montgomery S A.
Safety of mirtazapine: a review.
Int Clin Psychopharmacol.
1995;
10
(Suppl. 4)
37-45
-
6
Pezzilli R, Melandri R, Barakat B, Broccoli P L, Miglio F.
Pancreatic involvement associated with tricyclic overdose.
Ital J Gastroenterol Hepatol.
1998;
30
418-420
-
7
Roberge R J, Martin T G, Hodgman M, Benitez J G.
Acute chemical pancreatitis associated with a tricyclic antidepressant (clomipramine) overdose.
J Toxicol Clin Toxicol.
1994;
32
425-429
Dr. Martin Sommer
Department of Clinical Neurophysiology
University of Göttingen
v. Siebold-Straße 5
37075 Göttingen
Germany
